Alejandro Aballay, PhD

Adjunct Professor

265 JONES Building
Box 3580 DUMC
Durham, N.C. 27710
Phone: (919) 668-1783
Fax: (919) 684-2790
Email: a.aballay@duke.edu

 

research • biography • lab members • publications

Research:

Aballay_JBC_December4_cover

Our broad research program concerns the use of genetics, functional genomics, and neurobiological approaches to study mechanisms involved in the control of immune responses against microbial pathogens. Immune activation needs to be fine-tuned since deficient or excessive inflammation can lead to cancer, or conditions such as Crohn’s disease, rheumatoid arthritis, atherosclerosis, diabetes, and Alzheimer’s disease.

Recent studies from our laboratory indicate that different immune and cellular homeostatic mechanisms are regulated at the organismal level by the nervous system. We have demonstrated that specific neurons suppress innate immunity in the intestinal cells of the nematode Caenorhabditis elegans, Aballay_CurrBiol_coverin part by down-modulating a mitogen-activated protein kinase signaling pathway similar to the mammalian p38 MAPK pathway that is highly conserved across metazoans. We found that G-protein coupled receptors (GPCRs) participate in neural circuits that control a conserved p38/PMK-1 MAPK immune pathway and non-canonical and canonical XBP-1 unfolded protein response pathways that are expressed in non-neuronal tissues and that are necessary to alleviate the increased demand on protein folding during immune activation. We study: 1) neuronal circuits involved in the control of immune homeostasis, 2) receptors involved in pathogen recognition, 3) signaling molecules involvedkvir20.v004.i07.cover in the control of immune homeostasis, 4) neural responses to infections such as pathogen-induced neurodegeneration, and 5) molecular pathways involved in the control of recovery from bacterial infections.

Our studies are based on the general hypothesis that immune pathways are regulated at the cell-autonomous level and, by the nervous system, at the cell non-autonomous level. We are also taking advantage of the simple and well-studied nervous and immune systems of C. elegans can be translated to mammals by to develop a whole-animal high-throughput Cover EMBO reportssystem for chemical and genetic screens for novel immunomodulators. We also study the extent to which the basic cellular mechanisms identified in analyzing the role of selected genes and chemical compounds in mammalian stems.

The complex and tractable C. elegans system is excellent to study all aspects of the molecular basis of host-pathogen interactions. From the perspective of the pathogen, the experimental advantage of using C. elegans as a host is that thousands of bacterial clones from a mutagenized library can be individually screened for avirulent mutants on separate Petri plates seeded with C. elegans. On the other hand, the advantages of using C. elegans to study host responses to pathogen attack are the extensive genetic and genomic resources available, and the relative ease of identifying C. elegans mutants that exhibit altered susceptibility to pathogen attack. We take advantage of the Caenorhabditis elegans system as a fast track to identify and initially characterize both host and pathogen genes involved in the pathogenic relationship. We also study the role of these genes in a variety of mammalian systems. We use a number of human pathogens including Salmonella enterica, Yersinia pestis, Pseudomonas aeruginosa, Staphylococcus aureus, and Cryptococcus neoformans. Our studies involve diverse disciplines including microbiology, genetics, immunology, and neurobiology.

Related Content

Virulence Profile
Alejandro Aballay
Virulence 4:7, 1–3; October 1, 2013; © 2013 Landes Bioscience